05:04:49 EDT Thu 23 May 2024
Enter Symbol
or Name

Login ID:

News for C:OPTI from 2023-05-24 to 2024-05-23 - 33 items News ReleasesIn The NewsOther CAUS
2024-05-22 12:16C:OPTIOptimi Health Corp0.375News ReleaseOptimi signs LOI to provide GMP psilocybin to ATMA
2024-05-14 13:01C:OPTIOptimi Health Corp0.36News ReleaseOptimi Health receives COA for 40mg, 60mg MDMA capsules
2024-05-10 11:29C:OPTIOptimi Health Corp0.385News ReleaseOptimi Health plans close of final tranche of financing
2024-05-09 13:10C:OPTIOptimi Health Corp0.38News ReleaseOptimi Health receives export permit from Health Canada
2024-04-23 11:47C:OPTIOptimi Health Corp0.33News ReleaseOptimi partners with Kwantlen psilocybin research
2024-04-15 12:53C:OPTIOptimi Health Corp0.255News ReleaseOptimi Health completes three batches of MDMA API
2024-04-09 15:03C:OPTIOptimi Health Corp0.265News ReleaseOptimi Health signs psilocybin supply agreement
2024-04-02 11:30C:OPTIOptimi Health Corp0.245News ReleaseOptimi receives GMP analysis certificate for psilocybin
2024-03-26 11:28C:OPTIOptimi Health Corp0.23News ReleaseOptimi to supply MDMA to Tel Aviv University
2024-03-01 00:40C:OPTIOptimi Health Corp0.265SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-03-01 00:40C:OPTIOptimi Health Corp0.265SEDAR Interim MD & ASEDAR Interim MD & A
2024-02-28 11:52C:OPTIOptimi Health Corp0.29News ReleaseOptimi Health closes $555,010 first financing tranche
2024-02-12 10:06C:OPTIOptimi Health Corp0.34News ReleaseOptimi Health releases MDMA production video
2024-02-08 11:32C:OPTIOptimi Health Corp0.31News ReleaseOptimi Health arranges $1.5-million financing
2024-02-06 11:39C:OPTIOptimi Health CorpNews ReleaseOptimi Health to hold webinar Feb. 13
2024-01-19 09:48C:OPTIOptimi Health Corp0.305News ReleaseOptimi gets OK to increase quantities under HC licence
2024-01-03 10:25C:OPTIOptimi Health Corp0.30News ReleaseOptimi receives precursor licence to formulate MDMA
2023-12-07 10:50C:OPTIOptimi Health Corp0.16News ReleaseOptimi Health signs supply deal with Sunshine Earth
2023-11-28 12:51C:OPTIOptimi Health Corp0.19News ReleaseOptimi Health harvests 8 natural psilocybin genetics
2023-11-10 10:01C:OPTIOptimi Health Corp0.165News ReleaseOptimi Health resolves supply agreement dispute
2023-11-07 13:16C:OPTIOptimi Health Corp0.16News ReleaseOptimi appoints Chase as chief science officer
2023-11-02 13:57C:OPTIOptimi Health Corp0.17News ReleaseOptimi Health arranges $1-million debt financing
2023-09-14 16:18C:OPTIOptimi Health Corp0.19News ReleaseOptimi Health cheers phase 3 MAPS PTSD trial results
2023-09-07 11:15C:OPTIOptimi Health Corp0.19News ReleaseOptimi receives licence amendment from Health Canada
2023-09-05 14:34C:OPTIOptimi Health Corp0.19News ReleaseOptimi Health arranges $1-million debt financing
2023-08-22 18:35C:OPTIOptimi Health Corp0.20SEDAR Interim MD & ASEDAR Interim MD & A
2023-08-22 18:33C:OPTIOptimi Health Corp0.20SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-08-10 13:36C:OPTIOptimi Health Corp0.195News ReleaseOptimi Health arranges $3-million debt financing
2023-08-01 14:27C:OPTIOptimi Health Corp0.19News ReleaseOptimi completes GMP psilocybin extraction process
2023-07-27 12:38C:OPTIOptimi Health Corp0.205News ReleaseOptimi Health receives supply deal termination notice
2023-06-15 11:37C:OPTIOptimi Health Corp0.21News ReleaseOptimi Health to supply MDMA for Numinus trial
2023-05-25 20:07C:OPTIOptimi Health Corp0.23SEDAR MD & ASEDAR MD & A
2023-05-25 20:01C:OPTIOptimi Health Corp0.23SEDAR Interim Financial StatementsSEDAR Interim Financial Statements